Mersana Therapeutics Inc (MRSN)
2.33
-0.07
(-2.92%)
USD |
NASDAQ |
May 31, 16:00
2.335
0.00 (0.00%)
After-Hours: 20:00
Mersana Therapeutics Market Cap: 285.10M for May 31, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 31, 2024 | 285.10M |
| May 30, 2024 | 293.67M |
| May 29, 2024 | 287.55M |
| May 28, 2024 | 293.67M |
| May 24, 2024 | 291.22M |
| May 23, 2024 | 302.23M |
| May 22, 2024 | 314.47M |
| May 21, 2024 | 320.59M |
| May 20, 2024 | 338.94M |
| May 17, 2024 | 334.05M |
| May 16, 2024 | 315.69M |
| May 15, 2024 | 314.47M |
| May 14, 2024 | 319.36M |
| May 13, 2024 | 320.59M |
| May 10, 2024 | 331.60M |
| May 09, 2024 | 301.62M |
| May 08, 2024 | 416.03M |
| May 07, 2024 | 431.32M |
| May 06, 2024 | 428.26M |
| May 03, 2024 | 423.37M |
| May 02, 2024 | 411.13M |
| May 01, 2024 | 412.36M |
| April 30, 2024 | 387.88M |
| April 29, 2024 | 386.66M |
| April 26, 2024 | 359.74M |
| Date | Value |
|---|---|
| April 25, 2024 | 348.73M |
| April 24, 2024 | 352.40M |
| April 23, 2024 | 392.78M |
| April 22, 2024 | 385.44M |
| April 19, 2024 | 397.67M |
| April 18, 2024 | 408.69M |
| April 17, 2024 | 430.71M |
| April 16, 2024 | 460.08M |
| April 15, 2024 | 463.75M |
| April 12, 2024 | 466.19M |
| April 11, 2024 | 455.18M |
| April 10, 2024 | 453.34M |
| April 09, 2024 | 501.67M |
| April 08, 2024 | 509.01M |
| April 05, 2024 | 523.70M |
| April 04, 2024 | 520.03M |
| April 03, 2024 | 544.50M |
| April 02, 2024 | 516.36M |
| April 01, 2024 | 540.83M |
| March 28, 2024 | 543.44M |
| March 27, 2024 | 544.65M |
| March 26, 2024 | 521.60M |
| March 25, 2024 | 517.96M |
| March 22, 2024 | 570.12M |
| March 21, 2024 | 583.47M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
69.43M
Minimum
Oct 07 2019
1.890B
Maximum
Dec 23 2020
633.19M
Average
504.82M
Median
Apr 13 2020
Market Cap Benchmarks
| Amicus Therapeutics Inc | 2.903B |
| Insmed Inc | 8.182B |
| Altimmune Inc | 532.48M |
| InfuSystems Holdings Inc | 152.05M |
| Anavex Life Sciences Corp | 344.91M |
Market Cap Related Metrics
| PS Ratio | 7.274 |
| Price to Book Value | 10.19 |
| Price | 2.33 |
| Earnings Yield | -48.93% |